VVT Med (VVTM.V), a developer of minimally invasive solutions for venous disease, has entered the Dominican Republic market through a trial distribution and evaluation agreement with Antilles Medica, VVT said Thursday.
Under the terms, Antilles will serve as the exclusive distributor for VVT's ScleroSafe technology in the Dominican Republic for an initial evaluation period, with a pathway toward a five-year partnership.
The arrangement includes an initial purchase order for ScleroSafe Full Sets, reflecting Antilles' commercial commitment to the market entry process, VVT said.
VVT's entry into Dominican Republic complements the company's established foothold in the U.S. through its relationship with Northwell Health, and its active distribution platforms in India and South Korea.
Price: $0.20, Change: $-0.07, Percent Change: -24.53%